Department/Directorate Information
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment. The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.
The Drug Development Unit, within the ICR and Royal Marsden, is a dedicated Clinical Trials Unit, with bespoke facilities to conduct early phase clinical trials.
The Unit, led by Professor Johann de Bono, comprises of clinicians, scientists, data and study management staff, and focuses on providing a seamless conduit between pre-clinical drug discovery, proof of principle Phase-1 clinical trials and tumour specific evaluation of novel agents. The Unit undertakes both industry-sponsored and investigator-initiated trials of new anti-cancer drugs. The Unit is rapidly expanding and provides an excellent opportunity for the post holder to develop a variety of skillsets.
Summary of Role
We are looking for an enthusiastic and committed GCP Officer to work within the Drug Development Unit which undertakes early phase clinical trials of new anticancer drugs. We are a world class clinical trials unit based on a dedicated ward within the Royal Marsden Hospital, for the development of novel cancer therapeutics which we believe will improve the care of cancer patients. The post holder will play a major role in maintaining GCP compliance within the DDU.
Key Requirements
The post holder will hold a university degree in a scientific discipline or similar qualification. Be knowledgeable in ICH-GCP regulatory standards for the conduct of clinical trials and have experience of monitoring and pharmacovigilance of Phase I oncology clinical trials.
The post holder will provide full support to maintain GCP compliance within the ICR laboratories (Cancer Biomarker Team, PK/PD Laboratories and DMPK labs), supporting Clinical trials run by the DDU and/or other Units where applicable. The post holder must be organised and able to plan work around a busy clinical unit. They should have excellent communication skills and interpersonal skills, in order to interact effectively with unit staff.
Appointments will be up to one-year maternity cover. This post also benefits from generous annual leave entitlement and a pension.
To apply for this post, please submit an online application including a supporting statement, detailing reasons why you are applying for the post and include your CV. We encourage all applicants to access the job pack attached for more detailed information regarding this role.
Due to the high volumes of applications that we receive, we reserve the right to close the advert before the published closing date, once we have received a sufficient number of applications. Therefore, we advise that you to submit your application, as early as possible to avoid disappointment.